Diffuse Large B-Cell Lymphoma

Featured

News
ASH Choosing Widely Recommendations Impact Frequency of Surveillance Imaging in DLBCL
The rate of surveillance imaging of survivors of DLBCL decreased after the American Society of Hematology (ASH) Choosing Wisely campaign.
Videos
HCRU, Costs With CAR-T Therapy Compared to Transplantation for DLBCL
Karl Kilgore, PhD, discusses study results that showed greater HCRU and costs with CAR-T therapy than transplantation…
Conference Coverage
Comparison of HCRU and Costs Associated With Treatments for Relapsed/Refractory DLBCL
HCRU and costs associated with CAR-T therapy were greater than transplantation for DLBCL and cost offsets before and…
Conference Coverage
Polatuzumab Vedotin Plus Bendamustine-Rituximab Cost-Effective for DLBCL
Study results show polatuzumab vedotin plus bendamustine-rituximab is cost-effective in comparison to bendamustine-…
News
Real-World CAR-T Therapy Toxicity in Patients With DLBCL
More studies exploring real-world experience and data are necessary and will help define and refine management of…

News

ASH Choosing Widely Recommendations Impact Frequency of Surveillance Imaging in DLBCL
Real-World CAR-T Therapy Toxicity in Patients With DLBCL
Outcomes of CAR-T vs Alternate Therapies for DLBCL in the Real-World Setting
New Standard Treatment Approach for Patients With DLBCL

Guideline Updates

NCCN B-Cell Lymphomas Guideline Features Therapy Updates in Follicular Lymphoma, DLBCL

Videos

HCRU, Costs With CAR-T Therapy Compared to Transplantation for DLBCL
Back to Top